China Rheumatoid Arthritis Registry of Patients With Chinese Medicine

NCT05219214 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2022-02-15

No results posted yet for this study

Summary

A multi-center registration study of clinical characteristics of rheumatoid arthritis (RA) patients with Chinese medicine.

Conditions

Interventions

OTHER

Chinese medicine

There are no restrictions on TCM therapy, including Chinese herbal medicine, Chinese patent medicine, external treatment, acupuncture and moxibustion, etc

Sponsors & Collaborators

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2022-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05219214 on ClinicalTrials.gov